http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102526117-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c7c582c58ebb902c3111171ec32c641 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 |
| filingDate | 2012-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba2e2422d9e3fddf2a45e17ad662f361 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d56a7aede8397e16393d70847202a7b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f32f52fbe903190a837561882b7f706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e8d6f0380996f95d3ff302e95a4bd84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c56a3c1c0bb287d2c3f0b616987393aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f1e369670e75817f899740addb1c80 |
| publicationDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102526117-B |
| titleOfInvention | Use of nutgall in preparation antifungal medicine and antifungal medicine synergistic agent |
| abstract | The invention belongs to the technical field of medicine and particularly relates to a purpose of nutgall for preparing antifungal medicine and an antifungal medicine synergistic agent. In-vivo experiments show that the nutgall has a better treatment effect on fungal infection, and the antifungal medicine of fluconazole recovers the effect on drug resistance fungi, so the nutgall can be used for antifungal treatment and can be used as the synergistic agent of the antifungal medicine. A new purpose is opened up for the nutgall, the nutgall is used as the antifungal medicine and the synergistic agent of the antifungal medicine, new candidate medicine is provided for the fungal treatment, in addition, the antifungal effect of the existing medicine is improved, under the conditions that the clinical fungus drug resistance is gradually universal and the drug resistance degree is gradually severe day by day, the antifungal medicine recovers the effect on the drug resistance fungi, and the medicine dosage of the antifungal medicine is reduced, so the medical cost is saved for patients, and the toxic or side effect of the medicine is reduced. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110898151-A |
| priorityDate | 2012-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.